Form4insider filings, from the source

SEC Form 4 · accession 0001651844-17-000003

NYMOX PHARMACEUTICAL CORP · NYMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James George Robinson
Director
Period of report
May 26, 2017
Accepted (ET)
May 31, 2017 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 26, 2017P4,500$3.78A49,550ITrust
Common StockMay 26, 2017P3,800$3.75A2,961,350D
Common StockMay 26, 2017P4,500$3.76A2,965,850D
Common StockMay 26, 2017P120$3.77A2,965,970D
Common StockMay 26, 2017P2,110$3.79A2,968,080D
Common StockMay 26, 2017P3,970$3.80A2,972,050D
Common StockMay 26, 2017P7,800$3.81A2,979,850D
Common StockMay 26, 2017P6,200$3.82A2,986,050D
Common StockMay 26, 2017P10,000$3.83A2,996,050D
Common StockMay 26, 2017P1,500$3.87A2,997,550D
Common StockMay 30, 2017P3,500$3.82A3,001,050D
Common StockMay 30, 2017P2,200$3.85A3,003,250D
Common StockMay 30, 2017P1,800$3.86A3,005,050D
Common StockMay 30, 2017P2,500$3.90A3,007,550D
Common Stockholding———2,957,550D
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust
Common Stockholding———49,550ITrust

Table II — derivative securities

No Table II lines on this filing.